WuXi Biologics (Cayman) Inc. (HKG:2269)
33.36
+0.12 (0.36%)
Nov 12, 2025, 4:08 PM HKT
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of 135.59 billion as of November 12, 2025. Its market cap has increased by 102.18% in one year.
Market Cap
135.59B
Enterprise Value
131.95B
Revenue
21.98B
Ranking
n/a
PE Ratio
30.69
Stock Price
33.36
Market Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 32.04B to 135.59B, an increase of 323.20%. That is a compound annual growth rate of 18.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2025 | 135.59B | 88.06% |
| Dec 31, 2024 | 72.10B | -42.32% |
| Dec 29, 2023 | 124.99B | -50.53% |
| Dec 30, 2022 | 252.68B | -35.37% |
| Dec 31, 2021 | 390.94B | -6.90% |
| Dec 31, 2020 | 419.91B | 228.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 275.37B |
| Hansoh Pharmaceutical Group Company | 222.91B |
| JD Health International | 190.49B |
| Innovent Biologics | 146.01B |
| Sino Biopharmaceutical | 122.28B |
| Akeso | 106.02B |
| Sichuan Kelun-Biotech Biopharmaceutical | 95.37B |
| Alibaba Health Information Technology | 90.40B |